Inventor
DAI HONGJIU
CN3 patents
Patents
3 patentsUS11090335B2Aug 17, 2021
Chimeric antigen receptor targeting human NKG2DL and methods of preparing said receptor and pharmaceutical composition
NANJING KAEDI BIOTHERAPEUTICS LTD3 citations68
US11359012B1Jun 14, 2022
Specific chimeric antigen receptor cells targeting human CLDN18A2, preparation method and application thereof
NANJING KAEDI BIOTHERAPEUTICS LTD3 citations62
US11364267B1Jun 21, 2022
Bi-specific targeting human NKG2DL and CLDN18A2 chimeric antigen receptor cells, preparation method and application thereof
NANJING KAEDI BIOTHERAPEUTICS LTD0 citations55